journal articleLitStream CollectionReal world results regarding rosuvastatin and rivals2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00001pmid: N/A
journal articleLitStream CollectionPioglitazone pays dividends in type 2 diabetes mellitus2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00002pmid: N/A
journal articleLitStream CollectionReference pricing or HTA for obtaining best value from drugs?2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00003pmid: N/A
journal articleLitStream CollectionRosuvastatin reigns supreme for hypercholesterolaemia2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00004pmid: N/A
journal articleLitStream CollectionInsulin aspart and human insulin: a long-term economic comparison2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00005pmid: N/A
journal articleLitStream CollectionOseltamivir cost saving for influenza in Brazil2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00008pmid: N/A
journal articleLitStream CollectionRimonabant reimbursement should return in Germany?2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00007pmid: N/A
journal articleLitStream CollectionSitagliptin tops rosiglitazone for type 2 diabetes2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00006pmid: N/A
journal articleLitStream CollectionCapecitabine reduces cost burden of gastric cancer2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00011pmid: N/A
journal articleLitStream CollectionDarunavir + ritonavir good value for HIV-1 infections2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-200705400-00009pmid: N/A